Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001209191-22-036667

Director acquired 4,466 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Humer Kristian Director 2022-06-10 Grant or award +4,466 4,466 D
Derivatives
Humer Kristian Director 2022-06-10 Grant or award · Stock Option (Right to Buy) +14,550 14,550 D
Loading xslF345X03/doc4.xml…